P-76: Self-efficacy as an outcome of the new therapeutic education programme (AdoDiab-1) for adolescents (aged 13 to 18) living with type 1 diabetes and receiving care at Yaounde central hospital, Cameroon
R V Kamtchim TagneAbstract
Introduction
Complications associated with type 1 diabetes remain a significant public health issue. Whilst all patients are at risk, adolescents are particularly vulnerable due to this critical stage of development. Preventing these complications inevitably requires empowering these adolescents through education that is socially and culturally grounded. The development of a new, complexity-based educational programme (AdoDiab-1) appears to enhance self-efficacy in these patients
Objectives
The aim of this study was to assess the effect of a new therapeutic education programme (AdoDiab-1) on the self-efficacy of adolescents aged 13 to 18 living with type 1 diabetes
Methods
Using a pilot study and an experimental design, 18 adolescents being treated at Yaoundé Central Hospital in Cameroon were randomly and equitably assigned to two groups (control and experimental), and their self-efficacy was measured using the Self-Efficacy for Diabetes Self-Management (SEDM) scale before and after the intervention, with the results compared using a Student’s t-test. Logistic regression was used to model the relationship between the AdoDiab-1 programme and the self-efficacy of adolescents in the experimental group
Results
A comparison of the mean total scores on the self-efficacy scale (t = 6.90; p < 0.000; dm = 3.21; 95% CI = [2.24; 4.10]) post-intervention reveals a statistically significant difference between the experimental group and the control group. Similarly, the effect of the AdoDiab-1 programme on self-efficacy (t = 20.01; p = 0.000; dm = 3.14; 95% CI = [2.84; 3.43]) shows a statistically significant improvement in the total scores of adolescents who participated in the AdoDiab-1 programme. Furthermore, all sub-scales of this measure show statistically significant differences between the two groups.
Conclusions
The improvement in self-efficacy among adolescents in the experimental group demonstrates the programme’s (AdoDiab-1) effectiveness in addressing the actual needs of these patients.